Document Detail


Caspr2 antibodies in patients with thymomas.
MedLine Citation:
PMID:  20859119     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Myasthenia gravis is the best known autoimmune disease associated with thymomas, but other conditions can be found in patients with thymic tumors, including some that affect the central nervous system (CNS). We have become particularly interested in patients who have acquired neuromyotonia, the rare Morvan disease, or limbic encephalitis. Neuromyotonia mainly involves the peripheral nerves, Morvan disease affects both the peripheral nervous system and CNS, and limbic encephalitis is specific to the CNS. Many of these patients have voltage-gated potassium channel autoantibodies. All three conditions can be associated with thymomas and may respond to surgical removal of the underlying tumor together with immunotherapies and symptomatic treatments. Herein, we review the results of our recent studies that show that voltage-gated potassium channel autoantibodies are not principally directed against the potassium channels themselves but in some patients are directed against a protein that is complexed with potassium channels in both the peripheral nervous system and CNS, contactin-2 associated protein (Caspr2). These antibodies are common in the subgroup of patients with thymic malignancies.
Authors:
Angela Vincent; Sarosh R Irani
Related Documents :
22791189 - Epidemiology of non-hereditary angioedema.
15958099 - Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects.
19389519 - The prevalence of melanocytic nevi on the soles in the japanese population.
2545069 - Relationship between immunophenotype and the development of second primary neoplasms in...
1124789 - Studies in myasthenia gravis: early thymectomy. electrophysiologic and pathologic corre...
6354419 - Clinical trials and drug toxicity in the elderly. the experience of the eastern coopera...
23679889 - Impact of cardiac computed tomography of the interatrial septum before pulmonary vein i...
20500989 - Different roles of radical scavengers--ascorbate and urate in the cerebrospinal fluid o...
25476839 - Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer     Volume:  5     ISSN:  1556-1380     ISO Abbreviation:  J Thorac Oncol     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-22     Completed Date:  2011-01-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101274235     Medline TA:  J Thorac Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S277-80     Citation Subset:  IM    
Affiliation:
Department of Clinical Neurology, John Radcliffe Hospital, Oxford, United Kingdom. angela.vincent@imm.ox.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Autoantibodies / immunology*
Humans
Membrane Proteins / immunology*
Nerve Tissue Proteins / immunology*
Potassium Channels / metabolism
Thymoma / immunology*,  pathology
Thymus Neoplasms / immunology*,  pathology
Chemical
Reg. No./Substance:
0/Autoantibodies; 0/CNTNAP2 protein, human; 0/Membrane Proteins; 0/Nerve Tissue Proteins; 0/Potassium Channels

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The thymus and the immune system: layered levels of control.
Next Document:  The role of fine needle aspiration cytology in the diagnosis and management of thymic neoplasia.